Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 
An image of many Covid vaccine bottles.

Can Serology Tests and Seroprevalence Surveys Inform a More Effective Vaccine Roll Out?

Vaccines have become a central instrument of our long-term response to the pandemic. Vaccination campaigns have now started around the world and will confer significant direct protection against infection, severe illness, and death to those inoculated. It may also protect against transmission, though robust evidence is yet to be confirmed.

An image of the COVID vaccine.

To Increase Vaccine Manufacturing in LMICs, We Also Need to Strengthen Regulatory Capacity

A lot of recent discussions focus on how to expand COVID-19 vaccine manufacturing capacity in low- and middle-income countries (LMICs). The conversations highlight the importance of technology transfer and the capability of the tech transfer receiving sites (the facilities in these countries that would then produce vaccines locally), including having specialized equipment and personnel.